title: NextSeq 500 sequencing; Treatment with onvansertib, a specific PLK1 inhibitor, overcomes olaparib resistance in high-grade serous ovarian carcinoma patient-derived xenografts
identifiers.namespace: European Bioinformatics Institute
identifiers.id: E-MTAB-13055:31_MNHOC266_COMBO_2h